> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Drug Proprietary Names Best Practices
- URL: https://www.fdaweb.com/guide-on-drug-proprietary-names-best-practices/
- Published: 2020-12-09T12:00:00.000Z
- Updated: 2026-09-14T16:39:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148259

*Federal Register* notice: FDA has made available a draft guidance entitled “Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products.” The document describes ways to help minimize medication errors and otherwise avoid adoption of proprietary names that contribute to agency violations. It also describes the framework FDA uses in evaluating proposed proprietary names for nonprescription drug products, which is available to sponsors to use before marketing a nonprescription drug product bearing a particular proprietary name. To view the notice, click [here.](https://www.govinfo.gov/content/pkg/FR-2020-12-09/pdf/2020-27057.pdf?ref=fdaweb.com)